Francesco Negro
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
Gonvers J, Troilliet N, Negro F, Monnat M, Malinverni R, Dutoit V, Dufour F, Chuard C, Chave J, Cerny A, Borovicka J, Bernasconi E, Genné D, Mullhaupt B, Cavassini M, Heim M, Oneta C. Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study. Swiss Med Wkly 2010; 140:w13055.
19.07.2010Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
19.07.2010Swiss Med Wkly 2010; 140:w13055
Gonvers Jean-Jacques, Troilliet Nicolas, Negro Francesco, Monnat Martine, Malinverni Raffaelle, Dutoit Valérie, Dufour François, Chuard Christian, Chave Jean-Philippe, Cerny Andreas, Borovicka Jan, Bernasconi Enos, Genné Daniel, Mullhaupt Beat, Cavassini Matthias, Heim Markus H, Oneta Carl
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Rauch A, Hirschel B, Malinverni R, Moradpour D, Mullhaupt B, Witteck A, Beckmann J, Berg T, Bergmann S, Negro F, Telenti A, Bochud P, Swiss Hepatitis C Cohort Study, Heim M, Günthard H, Furrer H, Kutalik Z, Descombes P, Cai T, di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour J, Swiss HIV Cohort Study. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010; 138:1338-45, 1345.e1-7.
11.01.2010Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
11.01.2010Gastroenterology 2010; 138:1338-45, 1345.e1-7
Rauch Andri, Hirschel Bernard, Malinverni Raffaele, Moradpour Darius, Mullhaupt Beat, Witteck Andrea, Beckmann Jacques S, Berg Thomas, Bergmann Sven, Negro Francesco, Telenti Amalio, Bochud Pierre-Yves, Swiss Hepatitis C Cohort Study, Heim Markus, Günthard Huldrych F, Furrer Hansjakob, Kutalik Zoltán, Descombes Patrick, Cai Tao, di Iulio Julia, Mueller Tobias, Bochud Murielle, Battegay Manuel, Bernasconi Enos, Borovicka Jan, Colombo Sara, Cerny Andreas, Dufour Jean-François, Swiss HIV Cohort Study
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C
Bochud P, Negro F, Francioli P, Malinverni R, Cerny A, Moradpour D, Heim M, Borovicka J, Mullhaupt B, Dufour J, Bochud M, Overbeck K, Cai T, Swiss Hepatitis C Cohort Study Group. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. Journal of hepatology 2009; 51:655-66.
01.10.2009Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C
01.10.2009Journal of hepatology 2009; 51:655-66
Bochud Pierre-Yves, Negro Francesco, Francioli Patrick, Malinverni Raffaele, Cerny Andreas, Moradpour Darius, Heim Markus, Borovicka Jan, Mullhaupt Beat, Dufour Jean-François, Bochud Murielle, Overbeck Kathrin, Cai Tao, Swiss Hepatitis C Cohort Study Group
Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C
Bernsmeier C, Duong F, Christen V, Pugnale P, Negro F, Terracciano L, Heim M. Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C. J Hepatol 2008; 49:429-40.
30.04.2008Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C
30.04.2008J Hepatol 2008; 49:429-40
Bernsmeier Christine, Duong Francois H T, Christen Verena, Pugnale Paolo, Negro Francesco, Terracciano Luigi, Heim Markus H
Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C
Broers B, Helbling B, François A, Schmid P, Chuard C, Hadengue A, Negro F, Swiss Association for the Study of the Liver (SASL 18). Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C. Journal of hepatology 2005; 42:323-8.
01.03.2005Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C
01.03.2005Journal of hepatology 2005; 42:323-8
Broers Barbara, Helbling Beat, François Anne, Schmid Patrick, Chuard Christian, Hadengue Antoine, Negro Francesco, Swiss Association for the Study of the Liver (SASL 18)